Announces New President
CHESTER, N.Y., Sept. 4, 2018
/PRNewswire/ -- Repro Med
Systems, Inc. dba RMS Medical
Products (otcqx:REPR) today
announced that Donald B.
Pettigrew has been appointed to
the position of President and
Chief Commercial Officer.
Mr. Pettigrew comes to RMS
following a 23-year career in
the medical device industry,
where he has vast experience and
demonstrated success in the home
infusion space. He has held
senior leadership positions at
market leading medical firms
such as Moog, Inc., Baxter
(formerly Gambro) and Boston
Scientific. At Moog, he
led commercialization and
business development for the IV
infusion and enteral feeding
franchises in both the US and
OUS markets. Revenue grew
$37 million over the last 3
years under his leadership, with
annual revenues trending above
$125 million. Mr.
Pettigrew has extensive
knowledge and experience in the
home infusion market where he
has a strong track record of
driving growth and profitability
by executing on
commercialization strategies.
He is a well-rounded executive
that has worked across all
customer facing and operational
functions including sales,
business development,
manufacturing, supply chain, and
product development.
"After a very thorough search
process and being referred to us
by one of our largest customers
we are thrilled that Don has
joined our team here at RMS,"
said Dan Goldberger, Chairman
and interim Chief Executive
Officer. "We believe Don's
significant management
experience across the entire
commercialization process from
product inception to patient use
in the home infusion arena and
his longstanding professional
relationships will be invaluable
to the future of our company as
we work to grow the business and
better serve the needs of our
customers."
"RMS and its Freedom infusion
system have become household
names among patients and
customers who depend on its
reliable, user-friendly and
highly effective technology
platform for subcutaneous and IV
infusions," said Mr. Pettigrew.
"RMS is committed to developing
innovative technology that
empowers patients," he added.
"My priorities as President and
Chief Commercial Officer are to
leverage the talents of RMS'
staff and technology to grow
this business and improve
patient outcomes. I look
forward to this tremendous
opportunity to lead RMS into
this next stage of the Company's
history," said Mr. Pettigrew.
Prior to joining RMS, Mr.
Pettigrew held senior roles at
Moog, Inc. from 2011 to 2018 as
Group Director, Global Business
Development and Group Director,
Global Sales and Professional
Services. He was Vice President
of Sales at Baxter (formerly
Gambro Renal Products) from 2008
to 2011 and held various sales
management positions at Boston
Scientific from 1995 to 2008.
Mr. Pettigrew earned a BA in
Biology from the University of
Colorado, Boulder in 1990.
Forward-Looking StatementsThe
statements contained herein may
include prospects, statements of
future expectations and other
forward-looking statements that
are based on management's
current views and assumptions
and involve known and unknown
risks and uncertainties,
identified by words such as
"believe". Actual results,
performance or events may differ
materially from those expressed
or implied in such
forward-looking statements.
About RMS Medical ProductsThe
Company develops, manufactures
and commercializes medical
products used for home infusions
and suctioning. The FREEDOM
Syringe Infusion System
currently includes the
FREEDOM60® and FreedomEdge®
Syringe Infusion Drivers, RMS
Precision Flow Rate Tubing™ and
RMS HIgH-Flo Subcutaneous Safety
Needle Sets™. These devices are
used for infusions administered
in professional healthcare
settings as well as at home. The
Company's RES-Q-VAC® line of
medical suctioning products is
used by emergency medical
service providers in addition to
a variety of other healthcare
providers. For more information
about RMS Medical Products,
please visit www.rmsmedicalproducts.com.